Back
HFA Premium Access

Risk of heart failure related to non - ergot derived dopaminergic agonists in Parkinson disease. A meta-analysis of randomized controlled trials

Session: Poster Session 3 - Drug therapy, other
Topic: Drug therapy, other
Speaker: Mrs C. Ariano (Naples, IT)
Event: HEART FAILURE 2016

Congress Presentation

Add to my library

Like

About the speaker

Mrs Carmelina Ariano

Elena d'Aosta Hospital, Naples (Italy)
0 follower

9 more presentations in this session

Assessment of the use of ESC heart failure guideline recommended therapy among patients followed at a heart failure outpatient clinic participating in the ESC Heart Failure long-term Registry

Speaker: Doctor B. Muk (Budapest, HU)

Access
Abstract
Like
Thumbnail

Long-term follow up of hospitalized patients with systolic heart failure undergoing early treatment with beta-blockers more ivabradine: a randomized study

Speaker: Doctor F. Hidalgo Lesmes (Cordoba, ES)

Access
Abstract
Like
Thumbnail

Comparison of perindopril-amlodipine and losartan-amlodipine combinations in the management of hypertension in patients with metabolic syndrome

Speaker: Doctor J. Uzokov (Tashkent, UZ)

Access
Abstract
Like
Thumbnail

How do we use anticoagulation therapy in the era of novel drugs - results of FIRST II registryy

Speaker: Doctor T. Nociarova (Brno, CZ)

Access
Abstract
Like
Thumbnail

Cardioprotective effects of long-term high-dose therapy with atorvastatin in patients with STEMI in the prevention of chronic heart failure

Speaker: Professor V. Oleinikov (Penza, RU)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 3 - Drug therapy, other

Speakers: Mrs C. Ariano, Doctor B. Muk, Doctor F. Hidalgo Lesmes, Doctor J. Uzokov, Doctor T. Nociarova...
Access
Like
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources